Cart
sales@molnova.com
S961 TFA (1083433-49-1 free base)
CAS No. ——
S961 TFA (1083433-49-1 free base)( —— )
Catalog No. M30060 CAS No. ——
S961 TFA is A high affinity insulin receptor (IR) antagonist with IC50 for hir-a, hir-b and human insulin-like growth factor I receptor (higf-ir) at 0.048, 0.027 and 630 nM, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameS961 TFA (1083433-49-1 free base)
-
NoteResearch use only, not for human use.
-
Brief DescriptionS961 TFA is A high affinity insulin receptor (IR) antagonist with IC50 for hir-a, hir-b and human insulin-like growth factor I receptor (higf-ir) at 0.048, 0.027 and 630 nM, respectively.
-
DescriptionS961 TFA is A high affinity insulin receptor (IR) antagonist with IC50 for hir-a, hir-b and human insulin-like growth factor I receptor (higf-ir) at 0.048, 0.027 and 630 nM, respectively.(In Vitro):S961 also shows high-affinity to Rat IR and Pig IR with IC50s of 0.056 nM and 0.084 nM in PEG-assay, respectively.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight——
-
Molecular FormulaC211H297N55O71S2.xC2HF3O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameSequence:{Gly}{Ser}{Leu}{Asp}{Glu}{Ser}{Phe}{Tyr}{Asp}{Trp}{Phe}{Glu}{Arg}{Gln}{Leu}{Gly}{Gly}{Gly}{Ser}{Gly}{Gly}{Ser}{Ser}{Leu}{Glu}{Glu}{Glu}{Trp}{Ala}{Gln}{Ile}{Gln}{Cys}{Glu}{Val}{Trp}{Gly}{Arg}{Gly}{Cys}{Pro}{Ser}{Tyr} (Disulfide bridge: Cys33-Cys40)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Sch?ffer L, et al. A novel high-affinity peptide antagonist to the insulin receptor. Biochem Biophys Res Commun. 2008 Nov 14;376(2):380-3.
molnova catalog
related products
-
SEA-0400
SEA0400 is a selective inhibitor of the Na+/Ca2+?exchanger.
-
BLU2864
BLU2864 is an orally active, highly selective, ATP-competitive PRKACA inhibitor with an IC50 of 0.3 nM, exhibiting anti-tumor activity and potential applications in cancer and polycystic kidney disease research .
-
Murrangatin
Murrangatin may be a valuable anti-tumor-promoting agent, it can significantly inhibit Epstein-Barr virus early antigen (EBV-EA) activation, and preserve the high viability of Raji cells, it also exhibits cytotoxicity against cholangiocarcinoma cell line, KKU-100.
